Detalles de la búsqueda
1.
Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders.
Bioorg Med Chem
; 23(10): 2387-407, 2015 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25882525
2.
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors.
Bioorg Med Chem
; 22(15): 4135-50, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24980703
3.
Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90).
Bioorg Med Chem
; 21(22): 7047-63, 2013 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24100158
4.
Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Mol Cancer Ther
; 17(3): 603-613, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29237806
5.
Antitumor activity of edotecarin in breast carcinoma models.
Cancer Chemother Pharmacol
; 60(2): 229-35, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17089166
6.
Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
Sci Rep
; 7(1): 9226, 2017 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28835717
7.
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
Mol Cancer Ther
; 15(4): 628-39, 2016 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26939704
8.
Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy.
Eur J Cancer
; 41(10): 1453-9, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15913986
9.
Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effect.
ChemMedChem
; 10(2): 276-95, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25430902
10.
The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition.
Mol Oncol
; 8(8): 1495-507, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24962792
11.
Cell line identity finding by fingerprinting, an optimized resource for short tandem repeat profile authentication.
Genet Test Mol Biomarkers
; 17(3): 254-9, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23356232
12.
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia.
PLoS One
; 8(3): e58424, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23520509
13.
Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy.
Mol Cancer Ther
; 9(8): 2243-54, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20682657
14.
Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor.
J Med Chem
; 52(16): 5152-63, 2009 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-19603809
Resultados
1 -
14
de 14
1
Próxima >
>>